Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Abstract
General methods and strains of bacteria are described that dramatically simplify and streamline plasmid DNA production. In one preferred embodiment, endolysin mediated plasmid extraction combined with flocculation mediated removal of cell debris and host nucleic acids achieves increased yield and purity with simplified downstream purification and reduced waste streams, thus reducing production costs.
Core Innovation
The method increases the production yield of a covalently closed, super-coiled plasmid DNA vector that is non-repetitive and lacks direct repeats or long terminal repeats. It utilizes transformed bacterial cells grown at a reduced temperature during colony isolation and amplification to create a cryopreserved seed stock. This processing improves subsequent vector yield in culture compared with higher-temperature handling. [procedural detail omitted for safety]
The background section is not explicitly described in the patent. The disclosure also mentions plasmid recovery approaches involving endolysin-producing Escherichia coli, autolysis, or low-pH extraction to reduce genomic DNA and simplify purification. In addition, the summary reports temperature management during plasmid production yielding an increase in plasmid DNA over fermentation, predominantly as supercoiled plasmid.
Claims Coverage
The claims include one independent claim, claim 1, comprising one inventive feature directed to reduced-temperature growth before cryopreservation to improve plasmid DNA vector yield.
Reduced-temperature preparation of a cryopreserved seed stock
Claim 1 covers growing transformed bacterial cells at a reduced temperature during colony isolation and colony amplification to create a cryopreserved seed stock for a non-repetitive, covalently closed, super-coiled plasmid DNA vector. The claim states that this handling improves subsequent vector yield in shake flask or fermentation culture compared with growth at a higher temperature. [procedural detail omitted for safety]
The independent claim centers on preparing a cryopreserved seed stock through reduced-temperature growth of transformed bacterial cells to increase subsequent plasmid DNA vector yield.
Stated Advantages
The claim states that reduced-temperature growth before cryopreservation improves subsequent plasmid DNA vector yield in shake flask or fermentation culture compared with higher-temperature handling.
Documented Applications
The dependent claims specify Escherichia coli cells and a DNA vaccine plasmid encoding an H1 or H3 serotype influenza hemagglutinin gene.
Interested in licensing this patent?